WELLDOC, INC.

Has completed a strategic partnership with
Strategic Advisory See more


STEADYMED, LTD

Has issued $10,000,000

Series B Preferred Stock
Private Placements See more


CALIBRA MEDICAL, INC.

Has issued $10,000,000

Senior Subordinated Debt
Debt Capital Markets See more


IRX Therapeutics

Has completed a round of financing
Private Placements See more

ENVISIA THERAPEUTICS, INC.

Has completed a $25 ,000,000 Series A Financing in conjunction with the “spin –off” of certain assets and sciences from Liquidia
Private Placements See more

BAYER PLASMA, GmBH


An operating division of

Has been acquired by

Cerberus, LLC
Mergers & Acquisitions See more

ALPHA THERAPEUTICS, INC.

An operating division of
Has been acquired by
Mergers & Acquisitions See more


PINNACLE BIOLOGICS, INC.

Has completed its $6,000,000 Series A financing
Private Placements See more


SORBENT THERAPEUTICS, INC.

Has completed its spinout from Dow Chemical
Strategic Advisory See more

NOVALAR PHARMACEUTICALS, INC.
Has been acquired by


$65,000,000
Mergers & Acquisitions See more

LIQUIDIA TECHNOLOGIES, INC.

Has completed a global collaboration with

Strategic Advisory See more


INNFOCUS, LLC


Has completed a structured financing with
Mergers & Acquisitions See more


BOSTON SCIENTIFIC, INC.


Has completed a strategic review of its endoscopy business unit leading to its decision to optimize strategic alternatives through a tax-efficient “spin-off”
Strategic Advisory See more


CARDIOSOUTIONS, INC.


Has completed its $15,000,000 Series B financing led by
Private Placements See more



VERAX BIOMEDICAL, INC.


Has entered a Worldwide Commercialization Partnership with
Strategic Advisory See more


DEERAC FLUIDICS, INC.

Has been acquired by
Mergers & Acquisitions See more

CLAROS DIAGNOSTICS, INC.

Has been acquired by

Mergers & Acquisitions See more


BIOMERIX, INC.

Has completed a Strategic Investment by

Strategic Advisory See more


MIACOM DIAGNOSTICS

Has completed its equity financing from
Private Placements See more